Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease (HaploSCD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01461837
Recruitment Status : Active, not recruiting
First Posted : October 28, 2011
Last Update Posted : September 3, 2020
Sponsor:
Collaborators:
UCSF Benioff Children's Hospital Oakland
Medical College of Wisconsin
Washington University School of Medicine
Tufts Medical Center
University of California, San Francisco
University of California, Los Angeles
Miltenyi Biomedicine GmbH
Ann & Robert H Lurie Children's Hospital of Chicago
Information provided by (Responsible Party):
Mitchell Cairo, New York Medical College

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : June 2022
Estimated Study Completion Date : December 2025